5, Feb 2026
RapidAI Highlights Research Depth and Industry Leadership at ISC 2026 With 28 Clinical Abstracts
SAN MATEO, CA, Feb 5: RapidAI, the pioneer of deep clinical AI and global leader in enterprise imaging, today announced details of 28 scientific abstracts accepted at the International Stroke Conference (ISC) 2026, held February 4-6, at the Ernest N. Morial Convention Center in New Orleans. The abstracts span aneurysm monitoring, ischemic stroke detection, advanced imaging visualization, and radiology workflow optimization. Findings reflect the impact of deep clinical AI delivered through the Rapid Enterprise™ platform, designed to scale across radiology and acute workflows.
The clinical data demonstrate how RapidAI’s clinically validated, FDA-cleared AI solutions can improve diagnostic performance, reduce interpretation time, and deliver measurable efficiency and economic gains for stroke teams and radiology departments. Rapid’s unique approach, called Deep Clinical AI, delivers real results by providing not just triage notifications but also visualization, localization, characterization, and tracking changes over time. The following abstracts highlight this approach and will be presented at the time below during ISC. Additional RapidAI abstract descriptions accepted by ISC.
Date: February 5, 2026
Time: 12:30–2:30 p.m. CT
Location: Hall B, Poster Hall
Artificial Intelligence Augments Radiologists Capabilities in Tracking Aneurysm Growth Over Time
- The abstract evaluated longitudinal aneurysm measurements using RapidAI’s Aneurysm platform and compared them with neuroradiologists’ interpretations.
- Rapid detected 46% more clinically significant growth compared with neuroradiologists alone (27/28 incidents of aneurysm growth detected by Rapid vs. 14/28 aneurysms for neuroradiologists alone)
- The findings indicate that RapidAI’s Aneurysm platform reliably captures true linear growth while maintaining comparable specificity, supporting improved longitudinal monitoring and assessment of rupture risk, and potentially enabling earlier, life-saving interventions.
“Identifying true aneurysm growth over time is challenging, even for highly experienced neuroradiologists,” said Lead Author Jeremy Heit, MD, PhD. “Our findings suggest that deep clinical AI can serve as a valuable adjunct by consistently detecting subtle changes that are difficult to discern visually, helping support longitudinal assessment and more informed decision-making aimed at preventing aneurysm rupture and stroke.”
Reduced Interpretation Time, Improved Detection Accuracy of High-Grade Stenosis and Occlusions using Lumina 3D: A Multi-Reader, Multi-Case Study
- The study assessed the impact of Lumina 3D, Rapid’s automated 3D head-and-neck reconstructions, on stroke occlusion and stenosis detection and interpretation time.
- Across 20 cases involving 24 occlusions and 11 stenoses, diagnostic accuracy improved from 76.1% without Lumina 3D to 85.6% with Lumina 3D, a 9% improvement (p = 0.0004).
- Interpretation time decreased by an average of 34 seconds per case (p<0.05), with general radiologists achieving time savings of more than 1 minute per case.
- The study concludes that Lumina 3D can enhance stroke workflows by enabling faster and more accurate identification of clinically significant stroke findings, potentially enabling faster interventions and better outcomes for stroke patients.
Improving Efficiency and CT Technologists’ Workflow using Lumina 3D, an AI-Enhanced CT Head and Neck Reconstruction Solution
- With the shortage of CT techs nationwide, time savings and efficiency is increasingly important for diagnostic centers to keep up with the increase in imaging demands
- Abstract evaluating operational performance of CT techs before and after the implementation of Lumina 3D.
- Prior to deployment, manual reconstructions averaged 31 minutes per patient. Following implementation, automated reconstructions required 7 minutes, resulting in a 77.4% reduction in technologist time, or 24 minutes saved per image
- Based on monthly CTA volumes, the time savings translated to approximately 81.6 hours saved per month, enabling 108 additional scans and generating an estimated $43,000 in additional monthly imaging revenue. The results demonstrate how AI-driven automation can expand imaging capacity while reducing staff workload.
“These ISC abstracts reflect the depth and rigor of the clinical evidence supporting our unique solutions,” said Karim Karti, Chief Executive Officer of RapidAI, “Together, these studies demonstrate the power of deep clinical AI when it is seamlessly integrated across radiology and care team workflows and built on an enterprise-grade platform. Proof matters in AI, and these data show meaningful gains in diagnostic confidence and operational efficiency with RapidAI.”
In addition, RapidAI will be highlighting three abstracts based on data from its collaboration with the Florida Stroke Registry. The Registry consists of 190 stroke centers and hospitals across the state of Florida. Data from these centers is reported to the Registry and analyzed alongside RapidAI imaging metrics to help identify innovative ways to improve stroke care for Florida patients. Abstracts from this partnership highlight the importance of real-world stroke research in improving clinical understanding and patient outcomes.
The International Stroke Conference is the world’s leading meeting focused on the science and treatment of cerebrovascular disease, bringing together clinicians, researchers, and healthcare leaders from around the globe.
- 0
- By Neel Achary
5, Feb 2026
KIMSHEALTH Opens Developmental Pediatric Clinic at Its Attingal Medical Centre
Dr. M I Sahadulla, Chairman and Managing Director, KIMSHEALTH inaugurating the Developmental Pediatric Clinic, at KIMSHEALTH Medical Centre, Attingal. Dr. Deepa Binod, Consultant, Department of Developmental Pediatrics, KIMSHEALTH; Sudheer Mohammed, Cluster Manager, KIMSHEALTH Medical Centres; Jacob Mathew, DGM Operations, KIMSHEALTH; Jerry Philip, CEO, KIMSHEALTH; Dr. Babu George, Senior Consultant, Department of Developmental Pediatrics, KIMSHEALTH nearby.
Thiruvananthapuram, Feb 5: KIMSHEALTH has opened its Developmental Pediatric Clinic, at KIMSHEALTH Medical Centre, Attingal. The newly launched clinic is dedicated to the assessment and management of developmental, behavioural, and learning concerns in children. Care is delivered through a multidisciplinary, child-centred, and evidence-based approach, ensuring holistic support for children and their families.
The clinic was inaugurated by Dr. M I Sahadulla, Chairman and Managing Director, KIMSHEALTH. In his inaugural address, Dr.Sahadulla said, “In developmental pediatrics, timely identification and intervention can make a lasting difference for the children as well as their families. This department focuses not just treating conditions, but also on understanding each child’s development journey.”
Headed by Dr. Babu George, Senior Consultant, Department of Developmental Pediatrics, KIMSHEALTH, the clinic offers a comprehensive range of services, including Developmental Pediatric Consultation, Speech Therapy, Occupational Therapy, Psychological Counselling and Behavioural Therapy, Developmental Therapy, and Academic Support. The clinic will function from 9.00 am to 5.00 pm, Monday to Saturday.
Dr. Babu George, Senior Consultant, Department of Developmental Pediatrics, KIMSHEALTH welcomed the gathering. Dr.Deepa Binod, Consultant, Department of Developmental Pediatrics, KIMSHEALTH, proposed the vote of thanks.
4, Feb 2026
Fortis Shalimar Bagh Lights Up Delhi’s Tallest Tower in Purple for Cancer Awareness
New Delhi, Feb 04: In a powerful message to amplify cancer awareness and highlight the critical importance of early detection, timely treatment and united community action, Fortis Shalimar Bagh in partnership with Prasar Bharti organised a symbolic illumination ceremony of Delhi’s Tallest Tower – The iconic TV Tower in Pitampura (approximately 235 metres tall). The landmark was illuminated in purple, the global colour symbolising cancer awareness.
The event was inaugurated by Mr. Mahipal Singh Bhanot, Business Head & Operations Lead – NCR Projects, Fortis Healthcare Ltd., Mr. Naveen Sharma, Facility Director, Fortis Hospital Shalimar Bagh, senior dignitaries of Delhi Doordarshan and Fortis Shalimar Bagh Oncologists, reaffirming hope, resilience, and collective commitment in the fight against cancer.
Held under the theme #RoshniUmeedKi, the initiative transformed a prominent city landmark into a beacon of awareness and solidarity with cancer patients and survivors, bringing together healthcare leaders and public institutions in a unified stand against cancer. The purple illumination symbolised courage, hope, and survival, serving as a powerful reminder that cancer can be fought through awareness, early diagnosis, and collective support.
Speaking on the occasion, Mr Mahipal Singh Bhanot, Business Head & Operations Lead – NCR Projects, Fortis Healthcare Ltd. said,
“Cancer awareness goes beyond medical treatment -it is about empowering people with the right information at the right time. Through initiatives like these, we are taking the message of early detection and preventive care beyond hospital walls and into the heart of the community. Illuminating an iconic public landmark is a symbolic yet powerful way to remind citizens that cancer can be fought with awareness, timely screenings, and collective support.”
Mr. Naveen Sharma, Facility Director, Fortis Hospital Shalimar Bagh said,
“The illumination ceremony highlighted Fortis Healthcare’s ongoing commitment to community health, preventive care, and public education, while reinforcing the role of collaborative efforts between healthcare providers and national broadcasters in amplifying vital public health messages. With the message “One Tower. One Light. One
4, Feb 2026
Flying Smart:4Travel Platforms Helping You Save on Airfare
Travel in India often coincides with family visits, planned holidays, and spontaneous getaways. However, periods of high demand can lead to a sharp rise in airfares, making flight bookings a challenging decision for many travellers. To ease this, several travel platforms are currently offering attractive discounts, cashback deals, and limited-period offers to help flyers save on ticket costs.
Whether you’re travelling home, planning a short break, or exploring a new destination, choosing the right booking platform can make a noticeable difference to your overall travel spend.
Here’s a look at the top five travel websites offering some of the best flight ticket deals right now combining smart technology, user-friendly features, and value-driven offers to make your travel planning smoother and more affordable.
1. Wego
Wego stands out as one of the most user-friendly and data-rich platforms for finding real-time flight comparisons across airlines and travel agencies. This festive season, it’s rolling out exclusive app-only deals and fare alerts that help you book smarter and cheaper. Whether you’re planning a domestic getaway or an international escape, Wego ensures you never miss a low fare.
2. MakeMyTrip
MakeMyTrip’s festive campaigns are a traveler’s delight, offering cashback on select credit cards, wallet discounts, and coupon codes on flight bookings. Their “Festive Sale” often includes limited-time flash deals and discounts for round-trip bookings.
3. Cleartrip
Cleartrip’s festive flight offers are powered by exclusive partnerships with banks like HDFC, ICICI, and Axis, offering additional discounts when you pay via select cards. Plus, their Cleartrip Rewards program lets you earn points for every booking that can be redeemed for future travel.
4. Ixigo
Ixigo has quickly become a traveler’s favorite for its AI-powered fare alerts and Ixigo Money cashback offers. This festive season, the platform is running limited-time deals on domestic routes and bonus rewards for app bookings.
4, Feb 2026
World of Palates Sweetens the ‘Week of Love’ – Valentine’s Day with a Strawberry-Led Dessert Menu
This Valentine’s Day, World of Palates at CR2 Mall, Nariman Point is turning up the romance with a special dessert-forward celebration, inviting couples and dessert lovers alike to indulge in flavours that are playful, comforting and irresistibly indulgent. Known for its globally inspired vegetarian offerings, the restaurant is marking the season of love with a limited-edition Valentine’s dessert menu that puts strawberries centre stage.
Designed to be shared, savoured and swooned over, the menu highlights three delightful creations that perfectly capture the spirit of Valentine’s Day. The Strawberry Matilda Cake is a showstopper—rich, moist and layered with luscious strawberry goodness, making it a must-order for anyone celebrating love over dessert. Equally indulgent is the Strawberry Milkshake, a classic favourite elevated with creamy textures and fresh berry notes, ideal for couples looking to sip on something sweet together.
Adding a lighter yet equally exciting option to the lineup is the Strawberry & Cream Cheese Smoothie Bowl. Fresh, vibrant and beautifully balanced, this bowl blends fruity freshness with creamy richness, offering a refreshing twist for those who prefer their Valentine’s treats on the wholesome side without compromising on indulgence.
Whether it’s a casual date, a post-dinner dessert stop or a sweet surprise for someone special, World of Palates’ Valentine’s offerings are crafted to make moments feel memorable. The warm, welcoming ambience of the restaurant further sets the mood, making it an inviting spot to celebrate love in all its forms.
With its playful strawberry creations and signature approach to flavour, World of Palates invites guests to end their Valentine’s Day on a sweet note where every bite feels like a little celebration of love.
4, Feb 2026
Dr. Chiranjeevi Advocates Early Detection and Awareness on International Cancer Day at KIMS Hospitals
Hyderabad, Feb 4: Megastar and Padma Vibhushan awardee Dr. Chiranjeevi emphasized that cancer should not be viewed as a death sentence, highlighting the critical role of early detection in enabling patients to overcome the disease and lead normal lives.
Speaking at the International Cancer Day programme organized by KIMS Hospitals, Secunderabad, Dr. Chiranjeevi stated that cancer is largely linked to lifestyle choices rather than being a curse. Lighting the ceremonial lamp as the chief guest, he urged the public to change the perception that a cancer diagnosis equates to the end of life.
“When we see so many cancer survivors here today, it becomes clear how much effort doctors are putting in to save lives. If cancer is detected early, it can be treated successfully, and patients can return to normal life,” he said. He also expressed concern over the rising incidence of cancer in children, urging people to consult doctors promptly if symptoms appear.
Dr. B. Bhaskar Rao, CMD of KIMS Group of Hospitals, stressed the need to overcome fear and stigma associated with cancer, noting that advanced medical care, including robotic surgeries, is now available in India. “Earlier, patients had to travel abroad for cancer treatment. Today, patients from other countries are coming to India for advanced care,” he said, emphasizing that early diagnosis remains key to successful treatment.
Dr. Madhu Devarasetty, Senior Consultant Surgical Oncologist and Robotic Surgeon, highlighted that cancer is now being diagnosed in younger age groups, including children aged five and ten, due to factors such as genetics, radiation exposure, chemicals, lifestyle habits, and chronic conditions like diabetes. She added that public awareness is crucial, as many patients approach doctors only in advanced stages.
KIMS Hospitals has established a Cancer Fight Support Group to guide patients and families. During the event, cancer survivors shared their experiences, demonstrating that with timely treatment, patients can lead healthy lives and inspire others facing similar challenges.
The programme was attended by Medical Director Dr. Sambit Sahu, Medical Oncologist Dr. Narender Kumar Thota, cancer survivors, patients undergoing treatment, and healthcare professionals.
4, Feb 2026
Industry Leaders Welcome Union Budget 2026 Boost to India’s Biopharma and Healthcare Ecosystem
Mr. Sheetal Arora, Promoter & CEO, Mankind Pharma
“The Union Budget makes a clear and timely choice by placing biopharma at the centre of India’s next manufacturing wave, alongside other frontier sectors. As India’s disease burden shifts towards diabetes, cancer, and autoimmune disorders, and advanced NCD therapies gain wider adoption globally, the focus on biologics and biosimilars is both relevant and necessary. The Bio Pharma Shakti initiative recognises that longevity, quality of life, and affordability will define healthcare outcomes going forward.
The Finance Minister, Nirmala Sitharaman, has reinforced the Viksit Bharat vision through a ₹10,000 crore commitment to build a strong domestic biopharma ecosystem, strengthen institutions, upgrade the Central Drugs Standard Control Organization to global standards, and enable faster, predictable approvals. The full BCD exemption on 17 cancer drugs and targeted relief for rare diseases will further improve patient access while supporting innovation in high-need areas.
Over the coming years, the alignment of these reforms with the evolving **European Union–India trade framework will help Indian pharma move from scale to leadership, attract global investment, and strengthen India’s position as a trusted manufacturing and innovation partner in advanced therapies.”
Mr. Sanjiv Navangul, CEO, BSV ( A Mankind Group Company)
“The Union Budget 2026 provides much-deserved momentum for India’s biopharma journey. We welcome the government’s intent to strengthen the biopharma ecosystem, and the Biopharma Shakti initiative is an encouraging step in this direction. The focus on building scale across strategic and frontier sectors creates the right environment for long-term improvements in health outcomes. The initiative recognises the need for innovation and research while creating a conducive ecosystem for good health through knowledge sharing and technology.
Alongside this, the emphasis on driving research by setting up new National Institutes of Pharmaceutical Education and Research will not only build talent but also augment the research capabilities of the country.
Strengthening the regulatory landscape through a robust biopharma-focused network, including enhanced capacity and faster approval timelines, will further support innovation and improve patient access.
Further, the proposed investment of Rs 10,000 crore over five years, along with the emphasis on domestic production, will go a long way in strengthening supply security and reducing dependence on imports. This aligns with the vision of BSV, as we remain committed to making in India for India and the world.
Additionally, the Budget’s proposal to promote India as a global hub for sports goods is also encouraging. Improved access to quality sports equipment can help drive wider participation of women in sports while supporting healthier lifestyles.”
Dr. Ankit Gupta, Managing Director, Park Medi World Limited
“The Union Budget 2026 presents a comprehensive roadmap for strengthening India’s healthcare ecosystem at a time when the country’s disease burden is shifting towards non-communicable diseases such as diabetes, cancer, and autoimmune disorders, alongside a rapidly ageing population. The proposed addition of one lakh allied health professionals will help bridge workforce gaps across hospitals, rehabilitation centres, and community-based care settings. This is complemented by plans to train 1.5 lakh caregivers through NSQF-aligned, multi-skilled programmes, strengthening long-term, elderly, and post-acute care services.
The establishment of five regional medical tourism hubs in partnership with the private sector reinforces India’s ambition to emerge as a preferred global healthcare destination. For hospital networks such as Park Hospitals, these initiatives create meaningful opportunities to scale specialised allied services, strengthen geriatric and rehabilitation care, and contribute to medical value tourism aligned with national healthcare priorities.”
4, Feb 2026
VietJet Delivers Strong Q4 and Full-Year 2025 Performance, Accelerates Global Expansion
VietJet Aviation Joint Stock Company (HOSE: VJC) has reported a strong financial performance for the fourth quarter and full year 2025, reflecting the airline’s operational efficiency and resilient business model. As part of its international expansion strategy, VietJet launched two new international routes from India in 2025, strengthening direct connectivity between India and Vietnam and supporting the growing demand for tourism and business travel. These results provide a solid foundation for VietJet’s global expansion plans in 2026.
Sustained Profitability Driven by Operational Efficiency
According to its financial statements, VietJet recorded standalone revenue of VND 29,035 billion (approximately USD 1.11 billion) in Q4 2025, marking a 47 percent increase compared to the same period last year. For the full year 2025, standalone revenue reached VND 81,426 billion (approximately USD 3.13 billion), reflecting a year-on-year growth of 14 percent.
The airline’s consolidated revenue for the year stood at VND 82,093 billion (approximately USD 3.16 billion). Pre-tax profit reached VND 2,630 billion, while post-tax profit amounted to VND 2,123 billion, representing growth of 44.3 percent and 51.2 percent respectively. This performance exceeded the company’s annual target by more than 120 percent.
During the year, VietJet also issued 50 million new shares, increasing equity by VND 5,000 billion (approximately USD 192.6 million). This capital infusion will support the airline’s long-term growth and expansion plans.
Network Expansion Strengthens Market Presence
In the fourth quarter of 2025, VietJet operated 36,100 flights, serving over 6.7 million passengers. For the full year, the airline operated 153,000 flights and carried 28.2 million passengers, representing year-on-year growth of 9 percent in flights and 11.2 percent in passenger numbers. Total cargo transported during the year reached 113,923 tonnes.
In 2025, VietJet operated a total of 254 routes, including 52 domestic and 202 international routes. The airline launched 22 new routes, notably introducing direct services from Hyderabad and Bengaluru to Ho Chi Minh City, further enhancing connectivity between India and Vietnam.
Strengthening International Partnerships and Long-Term Investments
The fourth quarter of 2025 marked a significant milestone in VietJet’s long-term investment strategy, with the delivery of 22 new aircraft—the largest fleet expansion since the airline’s inception.
Additionally, VietJet signed an agreement with Airbus for the purchase of 100 A321neo aircraft. The airline also entered into a separate agreement with Rolls-Royce for 92 Trent 7000 engines along with comprehensive maintenance services, with a total estimated value of USD 3.8 billion.
Innovation, Technology and Global Recognition
Throughout 2025, VietJet continued to enhance its customer offerings, introducing services such as Business Class tickets, the SkyJoy loyalty program, in-flight retail, multi-channel booking and payment platforms, and the AI-powered virtual assistant “Amy.”
The airline received several international accolades in 2025, including recognition as one of the world’s safest airlines, “Best Ultra Low-Cost Airline,” and the AirlineRatings Sustainability Award. VietJet was also honoured as Asia’s Leading Airline for Customer Experience, ranked among ASEAN’s most valuable airline brands by Brand Finance, listed in Forbes Vietnam’s Top 50 Companies, certified as a Best Place to Work in Asia, and awarded the Gold ESG Transport Award in Taiwan.
Entering 2026 from a position of strength, VietJet is well poised to advance its strategy of sustainable growth and continued global expansion.
4, Feb 2026
A Valentine’s Day Crafted with Love: Celebrate Romance with Choko La’s Artisanal Chocolates, Cakes & Gifting
Feb 04: This Valentine’s Day, Choko La invites couples, friends, and families to celebrate love in its most indulgent form with a thoughtfully curated collection of artisanal chocolates, celebratory cakes, and bespoke gifting experiences. Designed to complement every kind of love story, the Valentine’s collection blends craftsmanship, emotion, and premium presentation—making every gift feel truly special.
At the heart of the collection are Choko La’s signature chocolate assortments, including Sweet Love, Berry Love, assorted truffles, and milk chocolate hearts. Crafted using authentic couverture chocolate, these creations deliver exceptional depth, smoothness, and flavour clarity. The range is further elevated with seasonal Valentine’s cakes and greeting cakes, designed to mark moments of celebration with decadence and heartfelt emotion.
Adding an experiential dimension to gifting, Choko La introduces interactive creations such as Chocolate Roses and the Hot Chocolate Kit – Valentine’s Edition, encouraging couples to share moments of joy and ritual. Romantic keepsake hampers pair handcrafted chocolates with rose bunches, designer cookies, and heart-shaped lollipops—creating gifts that linger long after they are unwrapped.
Each Valentine’s hamper is curated as a complete experience, ranging from compact chocolate boxes for intimate gestures to layered premium hampers for grand expressions of love. For customers seeking effortless gifting, Choko La stores will feature a limited selection of ready-to-pick Valentine’s hampers, including heart-themed chocolate boxes and pre-packed assortments designed for walk-in shoppers.
Personalisation remains central to the Choko La experience. Customers can customise hampers by mixing and matching chocolates, cookies, cakes, and kits; replacing products within standard hampers; or opting for chocolate-forward or bakery-led assortments. Greeting cakes, roses, and personalised message cards can also be added, making each gift a meaningful keepsake. The customisation option extends to bulk and corporate gifting, ensuring thoughtful solutions for every requirement.
All Valentine’s gifts are presented in exclusive seasonal packaging featuring heart-inspired designs, romantic colour palettes, and meticulously hand-arranged layouts. The luxurious, gift-ready presentation reflects Choko La’s premium ethos and commitment to detail.
To ensure availability, Choko La recommends placing custom hamper and cake orders 5–7 days in advance, while bulk and corporate orders should be placed 7–10 days prior. Home delivery is available across select cities, with multi-location delivery support enabling seamless long-distance gifting.
Valentine’s Day hampers start from ₹200 onwards and include Chocolate Indulgence Hampers, Chocolate & Bakery Hampers, Cake & Celebration Hampers, Premium Custom Hampers, and Interactive Gifting Kits. Highlights this season include Sweet Love, Berry Love, assorted truffles, milk chocolate hearts, seasonal Valentine’s cakes, designer cookies, heart lollipops, chocolate roses, and the Valentine’s Edition Hot Chocolate Kit.
This Valentine’s Day, Choko La transforms gifting into an expression of love—crafted with care, indulgence, and artistry.
4, Feb 2026
India–US Trade Deal Signals Transformational Shift in Strategic Economic Partnership
By:- Dinesh Kanabar, CEO and Chairman, Dhruva Advisors, on the India- US Trade Deal
The India–US FTA is far more than a trade arrangement—it signals a strategic reset in the economic partnership between the world’s oldest and largest democracies. Coming close on the heels of the India–UAE agreement, India has now effectively stitched market access with the most dynamic consumption and investment hubs. For Indian business, this is not incremental—it is transformational. It opens predictable entry into high-value supply chains, technology collaboration and services mobility that were earlier constrained by tariff and regulatory frictions.
Sectors with deep Indian capability stand to gain immediately. Textiles and apparel can re-emerge as global champions with duty rationalisation and rules-of-origin clarity. Pharmaceuticals and life sciences will benefit from faster approvals and trusted-partner frameworks. Fisheries, agri-processing and speciality chemicals gain scale through assured demand and standards alignment. Equally important is the signal to investors: India is now part of a coherent trade architecture spanning the Gulf and the US, offering a reliable alternative to concentrated sourcing elsewhere.
If executed with speed, this pact can redefine India from being a market to being a production base for the world—exactly the pivot our growth story needs.
